The latest news and insights from Genoa Healthcare.
Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview of the latest and connect with your local...
According to the CDC, flu season runs rampant from October through May.1 Looking to keep the people you serve safe during the 2023-2024 flu season? Keep these three trends on...
Genoa Healthcare’s latest drug trend report highlights information on new medication launches as well as noteworthy drug shortages currently in market. Brand name drug launches* Brixadi™ Zurzuvae™ (zuranolone) Generic drug...
Genoa Healthcare’s latest drug trend report highlights information on new medication launches as well as noteworthy drug shortages currently in market. Brand name drug launches* Uzedy Abilify Asimtuffii Brixadi Generic...
Narcan® information and sources were taken from www.narcan.com. 1. FDA Approves First Over-the-Counter Naloxone Nasal Spray. 3/29/2023. FDA Approves First Over-the-Counter Naloxone Nasal Spray | FDA
Information and sources on buprenorphine-containing products were taken from www.sublocade.com and www.suboxone.com.
1X-Waiver no longer need to treat opioid use disorder. (2023, January 13). ACEP. 2. Sublocade. 3.BMC launces app to help providers treat patients with opioid use disorder. (2021, March 22)....
For consumers living with opioid use disorder (OUD), medication-assisted treatment (MAT) has become the gold standard of treatment. In a new webinar, Genoa Healthcare Director of Operations Megan Garrity, PharmD,...
In a new webinar, Genoa Directors of Operations Joseph Pellerito and Katie Lozano share how organizations are addressing risks associated with transitions of care through unique partnerships and programs to...
Words matter when you provide care for people with substance use disorder (SUD), says Genoa pharmacist Shawn Zwilling. Zwilling’s pharmacy is located onsite at the St. Louis-based Assisted Recovery Centers...